An increasing number of older patients undergo heart surgery. Despite seemingly successful outcomes, these vulnerable patients may face prolonged decreased functional capacity, reduced self-efficacy, and impaired quality of life after discharge. Early engagement in physical activity and education plays a key role in health and well-being after heart surgery The goal of this clinical trial is to evaluate the effectiveness of an app-based exercise program and weekly calls from a physiotherapist in the early stages after open heart surgery. Eligible patients will be randomly assigned to either a control group receiving standard care or an intervention group, which will be introduced to an individually tailored exercise program as an addition to standard care. Follow-up is planned with an out-patient visit six weeks after discharge and a telephone interview six months post-surgery. All participants will undergo assessments at enrollment and during follow-up. Physical performance will be evaluated through physical tests. General well-being, quality of life, self-reported physical activity, and cost-effectiveness of the intervention will be assessed through questionnaires. Muscle health will be examined through blood sampling, CT scans, and muscle biopsies. The primary endpoint is the 30-second Chair Stand Test serving as a measurement of physical function.
Hypotheses: Primary: Early mobile health intervention at home supplemented by weekly calls from a physiotherapist after cardiac surgery improves functional outcomes, exercise tolerance, and quality of life in older patients. Secondary: * Cardiac surgery increases the prevalence and extent of sarcopenia in the elderly which can be mitigated by early mobile health intervention * Sarcopenia on Chest Computed Tomography (CCT) is strongly correlated to functional outcome and quality of life following cardiac surgery * Early mobile health intervention is feasible and cost-effective Design: This is a bi-center, prospective, randomized controlled, parallel, two-arm, open-label, blinded evaluation (PROBE) trial with a superiority design. The study population will consist of a representative group (n=120) of older patients scheduled for open heart surgery who fulfill the requirements according to inclusion and exclusion criteria. The patients will be recruited from 2 cardiac surgery centers in northern and central Denmark. Patients are stratified after center and subsequently randomly allocated (1:1) to receive mobile health intervention as an adjunct to standard care (Intervention Group), or standard care alone (Control group) for 6 weeks after discharge. Follow-up is planned with an outpatient visit 6 weeks after discharge, and a telephone interview 6 months after surgery. Patients in the intervention group receive a 6-week home-based CR using the ICURA app and sensor-based technology (ICURA ApS, Copenhagen, Denmark). During the hospital stay patients in the intervention group are introduced to the app's usage, and an individualized training plan is collaboratively created and subsequently tailored by a physiotherapist. The patients are equipped with a case including an ICURA -sensor with a charger, an illustrative quick guide, and a contact telephone number. According to the patient's preference, the app is either installed on their own mobile phone or provided on a separate mobile device. The comprehensive mobile health intervention includes customized training programs, activity tracking, visualization of exercises with videos, text message communication with patients, and a password-protected webpage for physiotherapists to customize training programs and track patient activity. A few days after discharge, patients in the intervention group will receive the first call from the physiotherapist, to ensure, that the patient is using the ICURA app actively. The patients will receive two calls per week for the first two weeks and as required the following four weeks.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
120
Six-week home-based rehabilitation program using the ICURA app and sensor-based technology (ICURA ApS, Copenhagen, Denmark). During the hospital stay patients in the intervention group are introduced to the app's usage, and an individualized training plan is collaboratively created and subsequently tailored by a physiotherapist. The comprehensive mobile health intervention includes customized training programs, activity tracking, visualization of exercises with videos, and a password-protected webpage for physiotherapists to customize training programs and track patient activity. The patients will receive two calls from a physiotherapist per week for the first two weeks and as required the following four weeks.
Aarlborg University Hospital
Aalborg, Denmark
Aarhus University Hospital
Aarhus, Denmark
Change (Δ) 30-second chair stand test (30CST) baseline vs. 6-week FU
Recording of the number of stands a person can complete from a chair without arms in 30 seconds
Time frame: 1-7 days prior to surgery and 6 weeks (+/- 4 days) after surgery
Change (Δ) in 10-meter Walk Test (10MWT) baseline vs. 6-week FU
Measurement of walking speed in meters per second over a 10-meter distance
Time frame: 1-7 days prior to surgery and 6 weeks (+/- 4 days) after discharge
Difference in 6-minute Walk Test (6MWT) between groups at 6-week FU
Measurement of walking distance in 6 minutes.
Time frame: 6 weeks (+/- 4 days) after discharge
Change (Δ) in WHO-5-score baseline vs. 6-week FU
5-item World Health Organization Well-Being Index (WHO-5), questionnaire assessing subjective well-being
Time frame: 1-7 days prior to surgery and 6 weeks (+/- 4 days) after discharge and 6 months after surgery
Change (Δ) in ASS-2-score baseline vs. 6-week FU
Anxiety Symptom Scale-2 (ASS-2), questionnaire assessing anxiety
Time frame: 1-7 days prior to surgery and 6 weeks (+/- 4 days) after discharge and 6 months after surgery
Change (Δ) in MDI-2-score baseline vs. 6-week FU
Major Depression Inventory-2 (MDI-2), questionnaire assessing depression
Time frame: 1-7 days prior to surgery and 6 weeks (+/- 4 days) after discharge and 6 months after surgery
Change (Δ) in Self-reported Physical Activity baseline vs. 6-week FU
Questionnaire assessing self-reported physical activity
Time frame: 1-7 days prior to surgery and 6 weeks (+/- 4 days) after discharge and 6 months after surgery
Change (Δ) in EuroQol-score baseline vs. 6-week FU
EuroQol-5-Dimension-5-Level Questionnaire (EQ-5D-5L), questionnaire assessing health-related quality of life
Time frame: 1-7 days prior to surgery and 6 weeks (+/- 4 days) after discharge and 6 months after surgery
Change in skeletal muscle mass baseline vs. 6-week FU
Body composition analysis with artificial-intelligence-assisted medical image analysis (CT scan) (DAFS©, Veronoi Health Analytics, Vancouver, Canada) to assess quantity and quality of skeletal muscle.
Time frame: 1-7 days prior to surgery and 6 weeks (+/- 4 days) after discharge
Cost-effectiveness analysis
Questionnaire assessing the cost-effectiveness of the intervention in comparison to usual care
Time frame: 1-7 days prior to surgery and 6 weeks (+/- 4 days) after discharge and 6 months after surgery
Changes in markers of musculoskeletal health through blood samples baseline vs. 6-week FU
Markers of muscle health: Myoglobin, Creatine Kinase (CK)
Time frame: 1-7 days prior to surgery and 6 weeks (+/- 4 days) after discharge
Changes in markers of inflammation through blood samples baseline vs. 6-week FU
Inflammatory markers: White Cell Count (WCC), Platelet Count, Mean Platelet Volume (MPV), Immature Platelet Fraction (IPF), High-Sensitive C-Reactive Protein (hs-CRP)
Time frame: 1-7 days prior to surgery and 6 weeks (+/- 4 days) after discharge
Changes in markers of nutrition through blood samples baseline vs. 6-week FU
Nutritional markers: Hemoglobin, Glycated Hemoglobin (HbA1c), fasting glucose, Albumin, Triglycerides, High-Density Lipoprotein (HDL), Low-Density Lipoprotein (LDL), Vitamin B12, Folate, 25-OH-Vitamin D2+D3
Time frame: 1-7 days prior to surgery and 6 weeks (+/- 4 days) after discharge
Changes in markers of liver function through blood samples baseline vs. 6-week FU
Liver Function Markers: Aspartate Aminotransferase (AST), Alanine Aminotransferase (ALT)
Time frame: 1-7 days prior to surgery and 6 weeks (+/- 4 days) after discharge
Changes in markers of kidney function through blood samples baseline vs. 6-week FU
Kidney Function Markers: Creatinine, estimated Glomerular Filtration Rate (eGFR)
Time frame: 1-7 days prior to surgery and 6 weeks (+/- 4 days) after discharge
Changes in markers of hormone levels through blood samples baseline vs. 6-week FU
Hormonal Markers: Cortisol, Free/Total Testosterone, Sex Hormone Binding Globulin (SHBG), Insulin-like Growth Factor-1 (IGF-1)
Time frame: 1-7 days prior to surgery and 6 weeks (+/- 4 days) after discharge
Assessment of muscle quality through obtainment of biopsies of the pectoralis major muscle at the surgery
Analysis of pectoralis major muscle biopsies
Time frame: At surgery
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.